Amplifon (BIT:AMP) Hasn't Managed To Accelerate Its Returns
Apr 07
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedApr 13, 2025
DataAggregated Company Financials
Companies16
- 7D-4.1%
- 3M-14.7%
- 1Y-14.5%
- YTD-13.6%
Over the last 7 days, the Healthcare industry has dropped 6.2%, driven by a pullback from Recordati Industria Chimica e Farmaceutica of 7.9%. Overall the industry is down 15% in 12 months. Earnings are forecast to grow by 7.5% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 13 Apr 2025 | €21.2b | €20.1b | €908.1m | 17.1x | 23.3x | 1.1x |
| Tue, 11 Mar 2025 | €23.9b | €20.1b | €810.9m | 23.2x | 29.5x | 1.2x |
| Thu, 06 Feb 2025 | €26.1b | €20.0b | €828.0m | 24.2x | 31.5x | 1.3x |
| Sat, 04 Jan 2025 | €24.1b | €8.0b | €834.7m | 22.9x | 28.9x | 3x |
| Mon, 02 Dec 2024 | €24.6b | €19.0b | €1.4b | 19x | 17.2x | 1.3x |
| Wed, 30 Oct 2024 | €25.7b | €18.9b | €1.4b | 19.4x | 18.6x | 1.4x |
| Fri, 27 Sep 2024 | €24.9b | €18.8b | €1.4b | 17.4x | 18.1x | 1.3x |
| Sun, 25 Aug 2024 | €25.7b | €18.9b | €1.4b | 15.1x | 18.6x | 1.4x |
| Tue, 23 Jul 2024 | €26.1b | €18.8b | €1.4b | 17.7x | 18.8x | 1.4x |
| Thu, 20 Jun 2024 | €25.7b | €18.8b | €1.4b | 16.1x | 18.6x | 1.4x |
| Sat, 18 May 2024 | €26.8b | €18.8b | €1.4b | 17.4x | 19.4x | 1.4x |
| Mon, 15 Apr 2024 | €25.0b | €18.7b | €1.4b | 19.4x | 18.2x | 1.3x |
| Wed, 13 Mar 2024 | €26.4b | €18.6b | €1.4b | 18.5x | 19x | 1.4x |
| Fri, 09 Feb 2024 | €24.7b | €18.6b | €1.4b | 18.8x | 17.8x | 1.3x |
| Sun, 07 Jan 2024 | €24.3b | €18.6b | €1.4b | 18.6x | 17.5x | 1.3x |
| Tue, 05 Dec 2023 | €22.8b | €18.6b | €1.4b | 18.7x | 16.4x | 1.2x |
| Thu, 02 Nov 2023 | €22.1b | €18.6b | €1.4b | 16.6x | 15.3x | 1.2x |
| Sat, 30 Sep 2023 | €22.6b | €17.3b | €1.1b | 14.7x | 19.9x | 1.3x |
| Mon, 28 Aug 2023 | €23.7b | €17.3b | €1.1b | 15.5x | 20.8x | 1.4x |
| Wed, 26 Jul 2023 | €23.9b | €7.7b | €822.5m | 15.9x | 29x | 3.1x |
| Fri, 23 Jun 2023 | €24.1b | €7.7b | €822.5m | 17.7x | 29.3x | 3.1x |
| Sun, 21 May 2023 | €25.0b | €7.7b | €823.4m | 22.5x | 30.4x | 3.2x |
| Tue, 18 Apr 2023 | €23.5b | €7.5b | €823.9m | 21.4x | 28.5x | 3.1x |
| Thu, 16 Mar 2023 | €23.0b | €7.5b | €867.3m | 23.2x | 26.5x | 3.1x |
| Sat, 11 Feb 2023 | €23.5b | €7.4b | €886.1m | 24.1x | 26.5x | 3.2x |
| Mon, 09 Jan 2023 | €23.7b | €7.4b | €886.1m | 23.7x | 26.7x | 3.2x |
| Wed, 07 Dec 2022 | €23.9b | €7.4b | €886.1m | 22x | 27x | 3.2x |
| Fri, 04 Nov 2022 | €22.9b | €7.3b | €895.7m | 21.2x | 25.5x | 3.1x |
| Sun, 02 Oct 2022 | €22.3b | €7.3b | €908.9m | 20.3x | 24.6x | 3.1x |
| Tue, 30 Aug 2022 | €24.0b | €7.2b | €886.8m | 23.4x | 27.1x | 3.4x |
| Thu, 28 Jul 2022 | €25.6b | €7.0b | €960.5m | 22.4x | 26.6x | 3.7x |
| Sat, 25 Jun 2022 | €24.8b | €6.9b | €957.4m | 20.4x | 25.9x | 3.6x |
| Mon, 23 May 2022 | €25.8b | €7.0b | €966.7m | 21.4x | 26.7x | 3.7x |
| Wed, 20 Apr 2022 | €29.8b | €6.8b | €952.4m | 23.6x | 31.3x | 4.4x |
Price to Earnings Ratio
31.3x
Current Industry PE
- Investors are relatively neutral on the Italian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 23.4x.
- The 3-year average PS ratio of 2.3x is higher than the industry's current PS ratio of 1.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 43% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | -1.96% | |
| Healthcare | -4.07% | |
| Biotech | 4.00% | |
| Life Sciences | 1.46% | |
| Medical Equipment | 0.84% | |
| Healthtech | 0% | 0 |
| Healthcare Services | -3.31% | |
| Pharma | -7.92% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry even though it's trading below its 3-year average PE ratio of 35.8x.
- Analysts are expecting annual earnings growth of 14.2%, which is lower than the prior year's growth of 61.4% per year.
- Investors are most pessimistic about the Healthtech industry, which is trading below its 3-year average of 55.5x.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 30% over the next 5 years.
- In contrast, the Biotech industry is expected to see its earnings decline by 112% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| DIA DiaSorin | €94.50 | 1.3% +€120.6m | 9.0% | PE27.1x | |
| PHIL Philogen | €20.70 | 4.0% +€32.2m | 14.0% | PE18.4x | |
| FF Fine Foods & Pharmaceuticals N.T.M | €6.94 | 1.5% +€2.4m | -16.2% | PE20.8x | |
| SVS Svas Biosana | €6.94 | 6.8% +€2.4m | -14.8% | PE6.9x | |
| ARBS Arterra Bioscience | €2.14 | 4.9% +€665.8k | 5.9% | PE10.6x |